GlassScriptPhysician profile
Nitin Bansal
NPI 1821487612
$9,415.41
in general payments reported to CMS, 2019-2025
13 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,985 · 2021: $3,602 · 2022: $1,782 · 2023: $630 · 2024: $401 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,045.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,691.79 | 2021-2022 | |
| Nevro Corp. | $2,378.54 | 2021-2024 | Senza |
| Medtronic USA, INC. | $1,985.45 | 2020 | |
| Globus Medical, INC. | $865.14 | 2025 | Senza, Vyrsa V1, Vyrsa Fix |
| Spr Therapeutics, INC | $272.93 | 2023-2025 | Sprint Pns System |
| Nalu Medical, INC. | $257.98 | 2022-2024 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $250.71 | 2021 | |
| Boston Scientific Corporation | $177.14 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $174.37 | 2021 | |
| Stratus Medical, LLC | $166.94 | 2022 | |
| Horizon Therapeutics Plc | $117.37 | 2021 | |
| Abbott Laboratories | $50.66 | 2024-2025 | Octrode, Proclaim |
| International Rehabilitative Sciences, INC | $26.39 | 2022-2023 | Rs 4i Plus Sequential Stimulator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Bansal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.